Actively Recruiting
Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort
Led by M.D. Anderson Cancer Center · Updated on 2026-05-11
20
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to study anxiety patterns in children aged 2 to 12 who are receiving radiation therapy at MD Anderson Cancer Center. The study focuses on understanding how anxiety changes during different stages of treatment and what factors might influence these anxiety levels. It is an observational study, meaning researchers will watch and record information without altering the treatment. The study will track anxiety using a special scale called the Modified Yale Preoperative Anxiety Scale Short Form (mYPAS-SF). Anxiety will be assessed at key points: during simulation, the first week of treatment, mid-treatment, and the final treatment week. Researchers will also look at how factors like the number of treatment sessions, use of anesthesia, support from child-life specialists, presence of parents or caregivers, waiting times, and time of day relate to anxiety. Participants will be observed during their regular radiation therapy appointments. The study will collect information on anxiety levels and related treatment details. Safety and any adverse events will be monitored throughout the study, which is expected to last about one year. This allows researchers to understand anxiety trends and how these might be connected to treatment experiences in pediatric patients.
CONDITIONS
Brief Title
Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provision of signed and dated informed consent from a parent or legal guardian.
- For children age 7 and older, provision of informed assent in addition to parental consent, consistent with institutional guidelines.
- Willingness of parent/guardian and child (as appropriate) to comply with study procedures.
- Male or female, ages 2-12 years.
- Scheduled to undergo radiation therapy at MD Anderson Cancer Center.
You will not qualify if you...
- Has already completed the simulation session for radiation therapy prior to enrollment.
- Declines parental consent or, when applicable, child assent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of radiation therapy course (varies per participant)
Participants undergoing radiation therapy are observed to measure procedural anxiety at key clinical milestones such as simulation, first week of treatment, mid-treatment, and final treatment week.
4 visits at standardized clinical milestones
Duration - Up to 1 year
Participants are monitored for safety and adverse events throughout the study period after radiation therapy completion.
Visits as needed for safety monitoring
Trial Site Locations
Total: 1 location
1
UT MD Anderson
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Susan L McGovern, MD, PHD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here